Shedding Light on the Mystery of Chronic Pain

Article

New breakthroughs in our understanding of the physical and biochemical pathways of pain may soon lead to effect disease-modifying drugs.

New breakthroughs in our understanding of the physical and biochemical pathways of pain may soon lead to effect disease-modifying drugs.

Watch as Elliot Krane, MD, director of Pain Management Services at Lucile Packard Children's Hospital at Stanford, gives a TED Talk on the “mystery of chronic pain.” He shares the story of a patient who fell and sprained her wrist, but presented to his clinic three months later suffering from dystonia and allodynia, with pain “that had spread from her wrist to her hands, to her fingertips, from her wrist up to her elbow, almost all the way to her shoulder.”

Krane discusses neurotransmitters; the role of glial cells “in the modulation, amplification, and in the case of pain, the distortion of sensory experiences;” and the various forms of therapy that can be employed to treat and manage chronic pain.

A complete interactive transcript of this presentation is also provided.

Related Videos
What Makes JAK Inhibitors Safe in Dermatology
Potential JAK Inhibitor Combination Regimens in Dermatology
Therapies in Development for Hidradenitis Suppurativa
"Prednisone without Side Effects": The JAK Inhibitor Ceiling in Dermatology
Discussing Changes to Atopic Dermatitis Guidelines, with Robert Sidbury, MD, MPH
How Will Upadacitinib, Povorcitinib Benefit Hidradenitis Suppurativa?
The JAK Inhibitor Safety Conversation
Jonathan Silverberg, MD, PhD, MPH | Credit: George Washington University
Secukinumab and Bimekizumab for Hidradenitis Suppurativa
© 2024 MJH Life Sciences

All rights reserved.